Provasctec
1 known investors
Provasctec develops a cell therapy combining mesenchymal stem cells with a biodegradable delivery device to create new vascular pathways, with a lead program targeting critical limb ischemia in peripheral artery disease patients. The company operates in regenerative medicine, applying biomaterial engineering and precision cell delivery to conditions including inflammation, cancer, and age-related diseases.
Founders & leadership
HM
Holger MullerCEO & Co-Founder
NC
Noel CapliceCSO & Co-Founder
Investors · 1
Frequently asked questions
- What does Provasctec do?
- Provasctec develops a cell therapy combining mesenchymal stem cells with a biodegradable delivery device to create new vascular pathways, with a lead program targeting critical limb ischemia in peripheral artery disease patients. The company operates in regenerative medicine, applying biomaterial engineering and precision cell delivery to conditions including inflammation, cancer, and age-related diseases.
- Who founded Provasctec?
- Provasctec was founded by Holger Muller, Noel Caplice.
- Who are Provasctec's investors?
- Provasctec's investors include NLC.